Functional NOS 1 in the rat mesenteric arterial bed

被引:17
作者
Sullivan, JC
Giulumian, AD
Pollock, DM
Fuchs, JC
Pollock, JS
机构
[1] Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA
[2] Med Coll Georgia, Dept Physiol, Augusta, GA 30912 USA
[3] Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2002年 / 283卷 / 02期
关键词
neuronal nitric oxide synthase activity; resistance arteries; vascular reactivity; subcellular fractionation;
D O I
10.1152/ajpheart.00073.2002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Previously we have demonstrated functional nitric oxide synthase (NOS) 1 in large arteries. Because resistance arteries largely determine blood pressure, this study examined whether functional NOS 1 also exists in resistance arteries. Phenylephrine (PE) contraction was measured in the absence and presence of the NOS 1 inhibitor N-5-(1-imino-3-butenyl)-L-ornithine (VNIO) in isolated mesenteric resistance arteries (endothelium intact and denuded) from Sprague-Dawley rats. For NOS 1 activity and expression, the mesenteric arterial bed was separated into cytosolic and particulate fractions. NOS activity was assayed by measuring the conversion of [H-3] arginine to [H-3] citrulline inhibited by a nonselective NOS inhibitor or VNIO. VNIO increased PE sensitivity in endothelium-intact and -denuded arteries. In cytosolic and particulate fractions of the arterial bed, similar to40% of NOS activity was inhibited by VNIO. Immunoprecipitation and Western blot analysis revealed two NOS 1 immunoreactive bands. One band corresponded to the rat brain isoform, whereas the second was of a slightly lower molecular mass. The cytosolic fraction contained both isoforms; however, the particulate fraction had only the lower molecular mass form. These studies demonstrate the existence of functional NOS 1 in resistance arteries.
引用
收藏
页码:H658 / H663
页数:6
相关论文
共 45 条
[1]   N5-(1-imino-5-butenyl)-L-ornithine -: A neuronal isoform selective mechanism-based inactivator of nitric oxide synthase [J].
Babu, BR ;
Griffith, OW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (15) :8882-8889
[2]   METHODOLOGICAL VARIABLES DURING ANALYSIS OF IN-VIVO CEREBELLAR CYCLIC-GMP, AN INDIRECT MARKER OF NITRIC-OXIDE RELEASE [J].
BANSINATH, M ;
ARBABHA, B ;
TURNDORF, H ;
GARG, UC .
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 1994, 31 (02) :107-112
[3]  
BEIRWALTES WH, 1995, AM J PHYSIOL, V269, pF134
[4]   Neuronal nitric oxide synthase is expressed in rat vascular smooth muscle cells -: Activation by angiotensin II in hypertension [J].
Boulanger, CM ;
Heymes, C ;
Benessiano, J ;
Geske, RS ;
Lévy, BI ;
Vanhoutte, PM .
CIRCULATION RESEARCH, 1998, 83 (12) :1271-1278
[5]  
BREDT DS, 1992, J BIOL CHEM, V267, P10976
[6]   ISOLATION OF NITRIC-OXIDE SYNTHETASE, A CALMODULIN-REQUIRING ENZYME [J].
BREDT, DS ;
SNYDER, SH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (02) :682-685
[7]   Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha 1-syntrophin mediated by PDZ domains [J].
Brenman, JE ;
Chao, DS ;
Gee, SH ;
McGee, AW ;
Craven, SE ;
Santillano, DR ;
Wu, ZQ ;
Huang, F ;
Xia, HH ;
Peters, MF ;
Froehner, SC ;
Bredt, DS .
CELL, 1996, 84 (05) :757-767
[8]   Regulation of neuronal nitric oxide synthase through alternative transcripts [J].
Brenman, JE ;
Xia, HH ;
Chao, DS ;
Black, SM ;
Bredt, DS .
DEVELOPMENTAL NEUROSCIENCE, 1997, 19 (03) :224-231
[9]   Functional expression of NOS 1 in vascular smooth muscle [J].
Brophy, CM ;
Knoepp, L ;
Xin, JD ;
Pollock, JS .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2000, 278 (03) :H991-H997
[10]   NITRIC-OXIDE AS AN INHIBITORY NONADRENERGIC NONCHOLINERGIC NEUROTRANSMITTER [J].
BULT, H ;
BOECKXSTAENS, GE ;
PELCKMANS, PA ;
JORDAENS, FH ;
VANMAERCKE, YM ;
HERMAN, AG .
NATURE, 1990, 345 (6273) :346-347